Klaus L. Dahmen

Klaus L. Dahmen has an extensive work experience in the medical industry, with a focus on sales and leadership roles. Starting in 1996, they served as an Area Sales Manager for Medtronic. Klaus L. then worked at LivaNova, where they held various positions, including Geographic Business Unit Sales Director / VP and Regional Sales Director. During their time at LivaNova, they were involved in the acquisition of Cyberonics. Following this, Klaus joined Interventional Spine as Vice President of Sales & Marketing until the company was acquired by DePuy Spine in 2017. Klaus L. then worked at Patient Care Automation Systems as the Senior Vice President of US Sales & Marketing before their acquisition. Klaus also held the role of Sales Director at Avinger Inc. and Vice President of Sales & Marketing at Ethos, Inc. Klaus L. later served as a Sales Director at Nuvectra and Sales Director at Vertiflex, which was acquired by Boston Scientific. Most recently, Klaus worked at Healent as Chief Commercial Officer and Board Member, and they currently hold the position of Vice President of Sales at Vivistim® Therapy for Stroke (MicroTransponder, Inc.), where they successfully launched Vivistim® in the US market.

Klaus L. Dahmen has pursued their undergraduate education in Business at the University of Wisconsin-Madison. Klaus L. then went on to further their studies at the University of Wisconsin-Whitewater, where they completed a Bachelor of Business Administration (BBA) degree in International Business.